Exact Mass: 548.2291

Bruceantin

C28H36O11 (548.2258)

Bruceantin is a triterpenoid. Bruceantin is a natural product found in Brucea javanica and Brucea antidysenterica with data available. Bruceantin is a triterpene quassinoid antineoplastic antibiotic isolated from the plant Brucea antidysenterica. Bruceantin inhibits the peptidyl transferase elongation reaction, resulting in decreased protein and DNA synthesis. Bruceantin also has antiamoebic and antimalarial activity. (NCI04) C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product > C1974 - Quassinoid Agent C784 - Protein Synthesis Inhibitor C1907 - Drug, Natural Product Bruceantin (NSC165563) can be extracted from B. javanica and has inhibitory effects on B16 melanoma, colon cancer 38, L1210 and leukemia P388. Bruceantin (NSC165563) can be extracted from B. javanica and has inhibitory effects on B16 melanoma, colon cancer 38, L1210 and leukemia P388.

PA(2:0/PGE2)

C25H41O11P (548.2386)

PA(2:0/PGE2) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/PGE2), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Prostaglandin E2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGE2/2:0)

C25H41O11P (548.2386)

PA(PGE2/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGE2/2:0), in particular, consists of one chain of one Prostaglandin E2 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/PGD2)

C25H41O11P (548.2386)

PA(2:0/PGD2) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/PGD2), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Prostaglandin D2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGD2/2:0)

C25H41O11P (548.2386)

PA(PGD2/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGD2/2:0), in particular, consists of one chain of one Prostaglandin D2 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C25H41O11P (548.2386)

PA(2:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Lipoxin A4 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/2:0)

C25H41O11P (548.2386)

PA(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/2:0), in particular, consists of one chain of one Lipoxin A4 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

12-O-Nortrilobine

C34H32N2O5 (548.2311)

Apateline

C34H32N2O5 (548.2311)

Briaranolide E

C28H36O11 (548.2258)

Tricordatine

C34H32N2O5 (548.2311)

3,7-Dihydroxy-4,5-dimethoxy-8-prenylflavan 7-O-beta-D-glucopyranoside

C28H36O11 (548.2258)

Kunzeaphlogin F

C24H36O14 (548.2105)

Nortrilobine

C34H32N2O5 (548.2311)

8-Acetylarteminolide

C32H36O8 (548.241)

Shizukaol J

C32H36O8 (548.241)

19-Epi-(+)-echitoveniline

C31H36N2O7 (548.2522)

[3R-(3alpha,4beta,5alpha,5aalpha,6alpha,9beta,9aalpha,10R*)]-5a-[(Acetyloxy)methyl]octahydro-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-4,5,6,9,10-pentol 5,10-diacetate 6-benzoate

C28H36O11 (548.2258)

Pachyclavulide C

C28H36O11 (548.2258)

Glabcensin R

C28H36O11 (548.2258)

Pachyovatamine

C34H32N2O5 (548.2311)

Asukamycin A-II

C31H36N2O7 (548.2522)

Asterriquinone SU-5500

C34H32N2O5 (548.2311)

Cycloshizukaol A

C32H36O8 (548.241)

A natural product found in Chloranthus japonicus.

Cocsoline

C34H32N2O5 (548.2311)

(+)-Cocsoline

C34H32N2O5 (548.2311)

6R,7E,9R-megastigma-4,7-dien-3-one 9,13-di-O-beta-D-glucopyranoside

C25H40O13 (548.2469)

12-O-acetylbriviolide D

C28H36O11 (548.2258)

C28H36O11

C28H36O11 (548.2258)

Teupyreinidin

C28H36O11 (548.2258)

artanomaloide

C32H36O8 (548.241)

4,8-dihydroxy-3-methoxy-11-oxo-1,6-dipentyl-11H-dibenzo[b,e][1,4]dioxepine-7-carboxylic acid benzyl ester

C32H36O8 (548.241)

1alpha,2alpha,6beta-Triacetoxy-9alpha-benzoyloxy-8alpha,15-dihydroxydihydro-beta-agarofuran

C28H36O11 (548.2258)

(Ra)-3-phenylacrylic acid 7-hydroxy-2,3,10,11,12-pentamethoxy-6,7-dimethyl-5,6,7,8-tetrahydrodibenzo[a,c]cycloocten-1-yl ester|neglschisandrin C

C32H36O8 (548.241)

isopatagonic acid

C32H36O8 (548.241)

Me glycoside,2,3-O-isopropylidene,tetra-Ac-4-O-alpha-D-Mannopyranosyl-L-rhamnose|Me glycoside,2,3-O-isopropylidene,tetra-Ac-4-O-beta-D-Galactopyranosyl-L-rhamnose|Me glycoside,2,3-O-isopropylidene,tetra-Ac-alphaalpha-Pyranose-4-O-beta-D-Glucopyranosyl-L-rhamnose

C24H36O14 (548.2105)

(1alpha,11beta)-23-ethoxy-1,2,21,23-tetrahydro-1,11-dihydroxy-21-oxoobacunone|23-ethoxy-21,23-dihydro-21-oxoclausenarin

C28H36O11 (548.2258)

1S,4S,5S,6R,7R,8R,9S,10S-9-benzoyloxy-1,6,15-triacetoxy-4,8-dihydroxy-dihydro-beta-agarofuran

C28H36O11 (548.2258)

(1S)-tetramethyl-1-O-methylnyasicoside

C28H36O11 (548.2258)

C25H40O13

C25H40O13 (548.2469)

lysidisides C

C24H36O14 (548.2105)

ARQ monoacetate

C34H32N2O5 (548.2311)

robustolide C

C28H36O11 (548.2258)

6,9-dihydroxymegastigmasta-5,7-dien-3-one 9-O-beta-D-gentiobioside

C25H40O13 (548.2469)

trigohowilol F

C35H32O6 (548.2199)

JBIR-52

C27H36N2O10 (548.237)

artanomadimer A

C32H36O8 (548.241)

Diosmetin 7-O-alpha-L-rhamnopyranosyl-(1?6)-beta-D-glucopyranoside|genipin 1-O-alpha-L-rhamnopyranosyl(1?6)-beta-D-glucopyranoside

C24H36O14 (548.2105)

klymollin J

C26H41ClO10 (548.2388)

artanomadimer F

C32H36O8 (548.241)

bruceanol-F

C28H36O11 (548.2258)

1S,4S,5S,6R,7R,8R,9S,10S-9-benzoyloxy-6,8,15-triacetoxy-1,4-dihydroxy-dihydro-beta-agarofuran

C28H36O11 (548.2258)

bistratamide I

C25H36N6O6S (548.2417)

A homodetic cyclic peptide that consists of L-valine and L-threonine as the amino acid residues. It is isolated from Lissoclinum bistratum and exhibits antitumour activity against the human colon tumour cell line.

(1R*,2R*,3R*,5Z,7S*,8(17)E,9S*,10S*,11R*,12S*,14S*)-2,3,9,14-tetraacetoxy-11,12-epoxybriara-5,8(17)-dien-18-one|excavatolide S

C28H36O11 (548.2258)

(1R*)-1-(furan-3-yl)-2-[(6aR,7R,8S,9R,10aS)-9-(beta-D-ribo-hexopyranosyl-3-uloseoxy)-3,5,6,6a,7,8,9,10-octahydro-7,8-dimethyl-3-oxonaphtho[1,8a-c]furan-7-yl]ethyl acetate|15,16-epoxy-12alpha-O-acetylcleroda-3,13(16),14-triene-18,19-olide-7alpha-O-beta-D-ribohexo-3-ulopyranoside|splendidin C

C28H36O11 (548.2258)

Ser Val Gln Glu Ser

C21H36N6O11 (548.2442)

Gly Arg Ser Asp Asp

C19H32N8O11 (548.219)

Ser Ser Val Gln Glu

C21H36N6O11 (548.2442)

Ala Ser Trp Trp

C28H32N6O6 (548.2383)

Ala Trp Ser Trp

C28H32N6O6 (548.2383)

Ala Trp Trp Ser

C28H32N6O6 (548.2383)

Cys Asp Arg Arg

C19H36N10O7S (548.2489)

Cys Ile Gln Trp

C25H36N6O6S (548.2417)

Cys Ile Trp Gln

C25H36N6O6S (548.2417)

Cys Leu Gln Trp

C25H36N6O6S (548.2417)

Cys Leu Trp Gln

C25H36N6O6S (548.2417)

Cys Gln Ile Trp

C25H36N6O6S (548.2417)

Cys Gln Leu Trp

C25H36N6O6S (548.2417)

Cys Gln Trp Ile

C25H36N6O6S (548.2417)

Cys Gln Trp Leu

C25H36N6O6S (548.2417)

Cys Arg Asp Arg

C19H36N10O7S (548.2489)

Cys Arg Arg Asp

C19H36N10O7S (548.2489)

Cys Trp Ile Gln

C25H36N6O6S (548.2417)

Cys Trp Leu Gln

C25H36N6O6S (548.2417)

Cys Trp Gln Ile

C25H36N6O6S (548.2417)

Cys Trp Gln Leu

C25H36N6O6S (548.2417)

Asp Cys Arg Arg

C19H36N10O7S (548.2489)

Asp Met Gln Arg

C20H36N8O8S (548.2377)

Asp Met Arg Gln

C20H36N8O8S (548.2377)

Asp Gln Met Arg

C20H36N8O8S (548.2377)

Asp Gln Arg Met

C20H36N8O8S (548.2377)

Asp Gln Thr Trp

C24H32N6O9 (548.2231)

Asp Gln Trp Thr

C24H32N6O9 (548.2231)

Asp Arg Cys Arg

C19H36N10O7S (548.2489)

Asp Arg Met Gln

C20H36N8O8S (548.2377)

Asp Arg Gln Met

C20H36N8O8S (548.2377)

Asp Arg Arg Cys

C19H36N10O7S (548.2489)

Asp Thr Gln Trp

C24H32N6O9 (548.2231)

Asp Thr Trp Gln

C24H32N6O9 (548.2231)

Asp Trp Gln Thr

C24H32N6O9 (548.2231)

Asp Trp Thr Gln

C24H32N6O9 (548.2231)

Glu His Thr Tyr

C24H32N6O9 (548.2231)

Glu His Tyr Thr

C24H32N6O9 (548.2231)

Glu Met Asn Arg

C20H36N8O8S (548.2377)

Glu Met Arg Asn

C20H36N8O8S (548.2377)

Glu Asn Met Arg

C20H36N8O8S (548.2377)

Glu Asn Arg Met

C20H36N8O8S (548.2377)

Glu Asn Thr Trp

C24H32N6O9 (548.2231)

Glu Asn Trp Thr

C24H32N6O9 (548.2231)

Glu Gln Ser Trp

C24H32N6O9 (548.2231)

Glu Gln Trp Ser

C24H32N6O9 (548.2231)

Glu Arg Met Asn

C20H36N8O8S (548.2377)

Glu Arg Asn Met

C20H36N8O8S (548.2377)

Glu Ser Gln Trp

C24H32N6O9 (548.2231)

Glu Ser Trp Gln

C24H32N6O9 (548.2231)

Glu Thr His Tyr

C24H32N6O9 (548.2231)

Glu Thr Asn Trp

C24H32N6O9 (548.2231)

Glu Thr Trp Asn

C24H32N6O9 (548.2231)

Glu Thr Tyr His

C24H32N6O9 (548.2231)

Glu Trp Asn Thr

C24H32N6O9 (548.2231)

Glu Trp Gln Ser

C24H32N6O9 (548.2231)

Glu Trp Ser Gln

C24H32N6O9 (548.2231)

Glu Trp Thr Asn

C24H32N6O9 (548.2231)

Glu Tyr His Thr

C24H32N6O9 (548.2231)

Glu Tyr Thr His

C24H32N6O9 (548.2231)

Phe Gly Tyr Tyr

C29H32N4O7 (548.2271)

Phe Tyr Gly Tyr

C29H32N4O7 (548.2271)

Phe Tyr Tyr Gly

C29H32N4O7 (548.2271)

Gly Phe Tyr Tyr

C29H32N4O7 (548.2271)

Gly Thr Trp Trp

C28H32N6O6 (548.2383)

Gly Trp Thr Trp

C28H32N6O6 (548.2383)

Gly Trp Trp Thr

C28H32N6O6 (548.2383)

Gly Tyr Phe Tyr

C29H32N4O7 (548.2271)

Gly Tyr Tyr Phe

C29H32N4O7 (548.2271)

His Glu Thr Tyr

C24H32N6O9 (548.2231)

His Glu Tyr Thr

C24H32N6O9 (548.2231)

His His Gln Gln

C22H32N10O7 (548.2455)

His Met Val Tyr

C25H36N6O6S (548.2417)

His Met Tyr Val

C25H36N6O6S (548.2417)

His Gln His Gln

C22H32N10O7 (548.2455)

His Gln Gln His

C22H32N10O7 (548.2455)

His Thr Glu Tyr

C24H32N6O9 (548.2231)

His Thr Tyr Glu

C24H32N6O9 (548.2231)

His Val Met Tyr

C25H36N6O6S (548.2417)

His Val Tyr Met

C25H36N6O6S (548.2417)

His Tyr Glu Thr

C24H32N6O9 (548.2231)

His Tyr Met Val

C25H36N6O6S (548.2417)

His Tyr Thr Glu

C24H32N6O9 (548.2231)

His Tyr Val Met

C25H36N6O6S (548.2417)

Ile Cys Gln Trp

C25H36N6O6S (548.2417)

Ile Cys Trp Gln

C25H36N6O6S (548.2417)

Ile Gln Cys Trp

C25H36N6O6S (548.2417)

Ile Gln Trp Cys

C25H36N6O6S (548.2417)

Ile Trp Cys Gln

C25H36N6O6S (548.2417)

Ile Trp Gln Cys

C25H36N6O6S (548.2417)

Leu Cys Gln Trp

C25H36N6O6S (548.2417)

Leu Cys Trp Gln

C25H36N6O6S (548.2417)

Leu Gln Cys Trp

C25H36N6O6S (548.2417)

Leu Gln Trp Cys

C25H36N6O6S (548.2417)

Leu Trp Cys Gln

C25H36N6O6S (548.2417)

Leu Trp Gln Cys

C25H36N6O6S (548.2417)

Met Asp Gln Arg

C20H36N8O8S (548.2377)

Met Asp Arg Gln

C20H36N8O8S (548.2377)

Met Glu Asn Arg

C20H36N8O8S (548.2377)

Met Glu Arg Asn

C20H36N8O8S (548.2377)

Met His Val Tyr

C25H36N6O6S (548.2417)

Met His Tyr Val

C25H36N6O6S (548.2417)

Met Asn Glu Arg

C20H36N8O8S (548.2377)

Met Asn Arg Glu

C20H36N8O8S (548.2377)

Met Asn Val Trp

C25H36N6O6S (548.2417)

Met Asn Trp Val

C25H36N6O6S (548.2417)

Met Gln Asp Arg

C20H36N8O8S (548.2377)

Met Gln Arg Asp

C20H36N8O8S (548.2377)

Met Arg Asp Gln

C20H36N8O8S (548.2377)

Met Arg Glu Asn

C20H36N8O8S (548.2377)

Met Arg Asn Glu

C20H36N8O8S (548.2377)

Met Arg Gln Asp

C20H36N8O8S (548.2377)

Met Val His Tyr

C25H36N6O6S (548.2417)

Met Val Asn Trp

C25H36N6O6S (548.2417)

Met Val Trp Asn

C25H36N6O6S (548.2417)

Met Val Tyr His

C25H36N6O6S (548.2417)

Met Trp Asn Val

C25H36N6O6S (548.2417)

Met Trp Val Asn

C25H36N6O6S (548.2417)

Met Tyr His Val

C25H36N6O6S (548.2417)

Met Tyr Val His

C25H36N6O6S (548.2417)

Asn Glu Met Arg

C20H36N8O8S (548.2377)

Asn Glu Arg Met

C20H36N8O8S (548.2377)

Asn Glu Thr Trp

C24H32N6O9 (548.2231)

Asn Glu Trp Thr

C24H32N6O9 (548.2231)

Asn Met Glu Arg

C20H36N8O8S (548.2377)

Asn Met Arg Glu

C20H36N8O8S (548.2377)

Asn Met Val Trp

C25H36N6O6S (548.2417)

Asn Met Trp Val

C25H36N6O6S (548.2417)

Asn Arg Glu Met

C20H36N8O8S (548.2377)

Asn Arg Met Glu

C20H36N8O8S (548.2377)

Asn Thr Glu Trp

C24H32N6O9 (548.2231)

Asn Thr Trp Glu

C24H32N6O9 (548.2231)

Asn Val Met Trp

C25H36N6O6S (548.2417)

Asn Val Trp Met

C25H36N6O6S (548.2417)

Asn Trp Glu Thr

C24H32N6O9 (548.2231)

Asn Trp Met Val

C25H36N6O6S (548.2417)

Asn Trp Thr Glu

C24H32N6O9 (548.2231)

Asn Trp Val Met

C25H36N6O6S (548.2417)

Gln Cys Ile Trp

C25H36N6O6S (548.2417)

Gln Cys Leu Trp

C25H36N6O6S (548.2417)

Gln Cys Trp Ile

C25H36N6O6S (548.2417)

Gln Cys Trp Leu

C25H36N6O6S (548.2417)

Gln Asp Met Arg

C20H36N8O8S (548.2377)

Gln Asp Arg Met

C20H36N8O8S (548.2377)

Gln Asp Thr Trp

C24H32N6O9 (548.2231)

Gln Asp Trp Thr

C24H32N6O9 (548.2231)

Gln Glu Ser Trp

C24H32N6O9 (548.2231)

Gln Glu Trp Ser

C24H32N6O9 (548.2231)

Gln His His Gln

C22H32N10O7 (548.2455)

Gln His Gln His

C22H32N10O7 (548.2455)

Gln Ile Cys Trp

C25H36N6O6S (548.2417)

Gln Ile Trp Cys

C25H36N6O6S (548.2417)

Gln Leu Cys Trp

C25H36N6O6S (548.2417)

Gln Leu Trp Cys

C25H36N6O6S (548.2417)

Gln Met Asp Arg

C20H36N8O8S (548.2377)

Gln Met Arg Asp

C20H36N8O8S (548.2377)

Gln Gln His His

C22H32N10O7 (548.2455)

Gln Arg Asp Met

C20H36N8O8S (548.2377)

Gln Arg Met Asp

C20H36N8O8S (548.2377)

Gln Ser Glu Trp

C24H32N6O9 (548.2231)

Gln Ser Trp Glu

C24H32N6O9 (548.2231)

Gln Thr Asp Trp

C24H32N6O9 (548.2231)

Gln Thr Trp Asp

C24H32N6O9 (548.2231)

Gln Trp Cys Ile

C25H36N6O6S (548.2417)

Gln Trp Cys Leu

C25H36N6O6S (548.2417)

Gln Trp Asp Thr

C24H32N6O9 (548.2231)

Gln Trp Glu Ser

C24H32N6O9 (548.2231)

Gln Trp Ile Cys

C25H36N6O6S (548.2417)

Gln Trp Leu Cys

C25H36N6O6S (548.2417)

Gln Trp Ser Glu

C24H32N6O9 (548.2231)

Gln Trp Thr Asp

C24H32N6O9 (548.2231)

Arg Cys Asp Arg

C19H36N10O7S (548.2489)

Arg Cys Arg Asp

C19H36N10O7S (548.2489)

Arg Asp Cys Arg

C19H36N10O7S (548.2489)

Arg Asp Met Gln

C20H36N8O8S (548.2377)

Arg Asp Gln Met

C20H36N8O8S (548.2377)

Arg Asp Arg Cys

C19H36N10O7S (548.2489)

Arg Glu Met Asn

C20H36N8O8S (548.2377)

Arg Glu Asn Met

C20H36N8O8S (548.2377)

Arg Met Asp Gln

C20H36N8O8S (548.2377)

Arg Met Glu Asn

C20H36N8O8S (548.2377)

Arg Met Asn Glu

C20H36N8O8S (548.2377)

Arg Met Gln Asp

C20H36N8O8S (548.2377)

Arg Asn Glu Met

C20H36N8O8S (548.2377)

Arg Asn Met Glu

C20H36N8O8S (548.2377)

Arg Gln Asp Met

C20H36N8O8S (548.2377)

Arg Gln Met Asp

C20H36N8O8S (548.2377)

Arg Arg Cys Asp

C19H36N10O7S (548.2489)

Arg Arg Asp Cys

C19H36N10O7S (548.2489)

Ser Ala Trp Trp

C28H32N6O6 (548.2383)

Ser Glu Gln Trp

C24H32N6O9 (548.2231)

Ser Glu Trp Gln

C24H32N6O9 (548.2231)

Ser Gln Glu Trp

C24H32N6O9 (548.2231)

Ser Gln Trp Glu

C24H32N6O9 (548.2231)

Ser Trp Ala Trp

C28H32N6O6 (548.2383)

Ser Trp Glu Gln

C24H32N6O9 (548.2231)

Ser Trp Gln Glu

C24H32N6O9 (548.2231)

Ser Trp Trp Ala

C28H32N6O6 (548.2383)

Thr Asp Gln Trp

C24H32N6O9 (548.2231)

Thr Asp Trp Gln

C24H32N6O9 (548.2231)

Thr Glu His Tyr

C24H32N6O9 (548.2231)

Thr Glu Asn Trp

C24H32N6O9 (548.2231)

Thr Glu Trp Asn

C24H32N6O9 (548.2231)

Thr Glu Tyr His

C24H32N6O9 (548.2231)

Thr Gly Trp Trp

C28H32N6O6 (548.2383)

Thr His Glu Tyr

C24H32N6O9 (548.2231)

Thr His Tyr Glu

C24H32N6O9 (548.2231)

Thr Asn Glu Trp

C24H32N6O9 (548.2231)

Thr Asn Trp Glu

C24H32N6O9 (548.2231)

Thr Gln Asp Trp

C24H32N6O9 (548.2231)

Thr Gln Trp Asp

C24H32N6O9 (548.2231)

Thr Trp Asp Gln

C24H32N6O9 (548.2231)

Thr Trp Glu Asn

C24H32N6O9 (548.2231)

Thr Trp Gly Trp

C28H32N6O6 (548.2383)

Thr Trp Asn Glu

C24H32N6O9 (548.2231)

Thr Trp Gln Asp

C24H32N6O9 (548.2231)

Thr Trp Trp Gly

C28H32N6O6 (548.2383)

Thr Tyr Glu His

C24H32N6O9 (548.2231)

Thr Tyr His Glu

C24H32N6O9 (548.2231)

Val His Met Tyr

C25H36N6O6S (548.2417)

Val His Tyr Met

C25H36N6O6S (548.2417)

Val Met His Tyr

C25H36N6O6S (548.2417)

Val Met Asn Trp

C25H36N6O6S (548.2417)

Val Met Trp Asn

C25H36N6O6S (548.2417)

Val Met Tyr His

C25H36N6O6S (548.2417)

Val Asn Met Trp

C25H36N6O6S (548.2417)

Val Asn Trp Met

C25H36N6O6S (548.2417)

Val Trp Met Asn

C25H36N6O6S (548.2417)

Val Trp Asn Met

C25H36N6O6S (548.2417)

Val Tyr His Met

C25H36N6O6S (548.2417)

Val Tyr Met His

C25H36N6O6S (548.2417)

Trp Ala Ser Trp

C28H32N6O6 (548.2383)

Trp Ala Trp Ser

C28H32N6O6 (548.2383)

Trp Cys Ile Gln

C25H36N6O6S (548.2417)

Trp Cys Leu Gln

C25H36N6O6S (548.2417)

Trp Cys Gln Ile

C25H36N6O6S (548.2417)

Trp Cys Gln Leu

C25H36N6O6S (548.2417)

Trp Asp Gln Thr

C24H32N6O9 (548.2231)

Trp Asp Thr Gln

C24H32N6O9 (548.2231)

Trp Glu Asn Thr

C24H32N6O9 (548.2231)

Trp Glu Gln Ser

C24H32N6O9 (548.2231)

Trp Glu Ser Gln

C24H32N6O9 (548.2231)

Trp Glu Thr Asn

C24H32N6O9 (548.2231)

Trp Gly Thr Trp

C28H32N6O6 (548.2383)

Trp Gly Trp Thr

C28H32N6O6 (548.2383)

Trp Ile Cys Gln

C25H36N6O6S (548.2417)

Trp Ile Gln Cys

C25H36N6O6S (548.2417)

Trp Leu Cys Gln

C25H36N6O6S (548.2417)

Trp Leu Gln Cys

C25H36N6O6S (548.2417)

Trp Met Asn Val

C25H36N6O6S (548.2417)

Trp Met Val Asn

C25H36N6O6S (548.2417)

Trp Asn Glu Thr

C24H32N6O9 (548.2231)

Trp Asn Met Val

C25H36N6O6S (548.2417)

Trp Asn Thr Glu

C24H32N6O9 (548.2231)

Trp Asn Val Met

C25H36N6O6S (548.2417)

Trp Gln Cys Ile

C25H36N6O6S (548.2417)

Trp Gln Cys Leu

C25H36N6O6S (548.2417)

Trp Gln Asp Thr

C24H32N6O9 (548.2231)

Trp Gln Glu Ser

C24H32N6O9 (548.2231)

Trp Gln Ile Cys

C25H36N6O6S (548.2417)

Trp Gln Leu Cys

C25H36N6O6S (548.2417)

Trp Gln Ser Glu

C24H32N6O9 (548.2231)

Trp Gln Thr Asp

C24H32N6O9 (548.2231)

Trp Ser Ala Trp

C28H32N6O6 (548.2383)

Trp Ser Glu Gln

C24H32N6O9 (548.2231)

Trp Ser Gln Glu

C24H32N6O9 (548.2231)

Trp Ser Trp Ala

C28H32N6O6 (548.2383)

Trp Thr Asp Gln

C24H32N6O9 (548.2231)

Trp Thr Glu Asn

C24H32N6O9 (548.2231)

Trp Thr Gly Trp

C28H32N6O6 (548.2383)

Trp Thr Asn Glu

C24H32N6O9 (548.2231)

Trp Thr Gln Asp

C24H32N6O9 (548.2231)

Trp Thr Trp Gly

C28H32N6O6 (548.2383)

Trp Val Met Asn

C25H36N6O6S (548.2417)

Trp Val Asn Met

C25H36N6O6S (548.2417)

Trp Trp Ala Ser

C28H32N6O6 (548.2383)

Trp Trp Gly Thr

C28H32N6O6 (548.2383)

Trp Trp Ser Ala

C28H32N6O6 (548.2383)

Trp Trp Thr Gly

C28H32N6O6 (548.2383)

Tyr Glu His Thr

C24H32N6O9 (548.2231)

Tyr Glu Thr His

C24H32N6O9 (548.2231)

Tyr Phe Gly Tyr

C29H32N4O7 (548.2271)

Tyr Phe Tyr Gly

C29H32N4O7 (548.2271)

Tyr Gly Phe Tyr

C29H32N4O7 (548.2271)

Tyr Gly Tyr Phe

C29H32N4O7 (548.2271)

Tyr His Glu Thr

C24H32N6O9 (548.2231)

Tyr His Met Val

C25H36N6O6S (548.2417)

Tyr His Thr Glu

C24H32N6O9 (548.2231)

Tyr His Val Met

C25H36N6O6S (548.2417)

Tyr Met His Val

C25H36N6O6S (548.2417)

Tyr Met Val His

C25H36N6O6S (548.2417)

Tyr Thr Glu His

C24H32N6O9 (548.2231)

Tyr Thr His Glu

C24H32N6O9 (548.2231)

Tyr Val His Met

C25H36N6O6S (548.2417)

Tyr Val Met His

C25H36N6O6S (548.2417)

Tyr Tyr Phe Gly

C29H32N4O7 (548.2271)

Tyr Tyr Gly Phe

C29H32N4O7 (548.2271)

GRSDD

C19H32N8O11 (548.219)

SVQES

C21H36N6O11 (548.2442)

SSVQE

C21H36N6O11 (548.2442)

3β-ACETOXY-23-BROMO-ISOALLOSPIROST-9 (11)-ENE-12-ONE

C29H41BrO5 (548.2137)

quinine bisulfate heptahydrate

C20H40N2O13S (548.2251)

(+)-N,N-(1S,2S)-1,2-DIAMINOCYCLOHEXANEDIYLBIS(2-PYRIDINECARBOXAMIDE)

C30H32N2O8 (548.2159)

ICG-001

C33H32N4O4 (548.2423)

H-Cys-Val-2-Nal-Met-OH

C26H36N4O5S2 (548.2127)

Fmoc-Gln(Tmob)-OH

C30H32N2O8 (548.2159)

butane-1,4-diol,ethane-1,2-diol,hexanedioic acid,1-isocyanato-4-[(4-isocyanatophenyl)methyl]benzene

C27H36N2O10 (548.237)

Bruceanol F

C28H36O11 (548.2258)

A quassinoid isolated from Brucea antidysenterica and has been shown to exhibit in vitro cytotoxicity towards several human tumour cell lines.

(6R,9aR)-6-[(4-hydroxyphenyl)methyl]-8-(1-naphthalenylmethyl)-4,7-dioxo-N-(phenylmethyl)-3,6,9,9a-tetrahydro-2H-pyrazino[1,2-a]pyrimidine-1-carboxamide

C33H32N4O4 (548.2423)

Terbutaline sulfate

C24H40N2O10S (548.2404)

D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents

[(2R,3R,4S,5S)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-hydroxy-4-(methylamino)oxan-3-yl] dihydrogen phosphate

C18H37N4O13P (548.2095)

(2S,3S,4S,5R)-6-[(3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[(2R)-4-[(1R)-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl]butan-2-yl]oxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C25H40O13 (548.2469)

PA(2:0/PGE2)

C25H41O11P (548.2386)

PA(PGE2/2:0)

C25H41O11P (548.2386)

PA(2:0/PGD2)

C25H41O11P (548.2386)

PA(PGD2/2:0)

C25H41O11P (548.2386)

PA(2:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C25H41O11P (548.2386)

PA(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/2:0)

C25H41O11P (548.2386)

Picras-3-en-21-oic acid, 15-((3,4-dimethyl-1-oxo-2-pentenyl)oxy)-13,20-epoxy-1,11,12-trihydroxy-2,16-dioxo-,methyl ester, (1beta,11beta,12alpha,15beta(E))-

C28H36O11 (548.2258)

1-[[(2R,3R)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea

C27H31F3N4O5 (548.2246)

1-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-[4-(trifluoromethyl)phenyl]urea

C27H31F3N4O5 (548.2246)

2-[(2R,4aR,12aR)-5-methyl-6-oxo-8-[(1-oxo-2-thiophen-2-ylethyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide

C29H32N4O5S (548.2093)

2-[(2S,4aS,12aS)-5-methyl-6-oxo-8-[(2-thiophen-2-ylacetyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide

C29H32N4O5S (548.2093)

2-[(2R,4aR,12aS)-5-methyl-6-oxo-8-[(1-oxo-2-thiophen-2-ylethyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide

C29H32N4O5S (548.2093)

2-[(2R,4aS,12aR)-5-methyl-6-oxo-8-[(1-oxo-2-thiophen-2-ylethyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide

C29H32N4O5S (548.2093)

1-[[(2R,3R)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea

C27H31F3N4O5 (548.2246)

1-[[(2S,3R)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea

C27H31F3N4O5 (548.2246)

1-[[(2S,3S)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea

C27H31F3N4O5 (548.2246)

1-[[(2R,3S)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea

C27H31F3N4O5 (548.2246)

1-[[(2S,3R)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea

C27H31F3N4O5 (548.2246)

1-[[(2R,3S)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea

C27H31F3N4O5 (548.2246)

1-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-[4-(trifluoromethyl)phenyl]urea

C27H31F3N4O5 (548.2246)

1-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-[4-(trifluoromethyl)phenyl]urea

C27H31F3N4O5 (548.2246)

1-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-[4-(trifluoromethyl)phenyl]urea

C27H31F3N4O5 (548.2246)

2-[(2S,4aS,12aR)-5-methyl-6-oxo-8-[(1-oxo-2-thiophen-2-ylethyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide

C29H32N4O5S (548.2093)

2-[(2S,4aR,12aS)-5-methyl-6-oxo-8-[(1-oxo-2-thiophen-2-ylethyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide

C29H32N4O5S (548.2093)

N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-(2-thiazolyl)benzamide

C30H36N4O4S (548.2457)

1-[[(2S,3S)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea

C27H31F3N4O5 (548.2246)

1-[[(2R,3S)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea

C27H31F3N4O5 (548.2246)

1-[[(2R,3R)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea

C27H31F3N4O5 (548.2246)

1-[[(2R,3S)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea

C27H31F3N4O5 (548.2246)

1-[[(2S,3S)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea

C27H31F3N4O5 (548.2246)

1-[[(2S,3R)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea

C27H31F3N4O5 (548.2246)

1-[[(2S,3R)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea

C27H31F3N4O5 (548.2246)

1-[[(2S,3S)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea

C27H31F3N4O5 (548.2246)

1-[[(2R,3R)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea

C27H31F3N4O5 (548.2246)

(2R)-2-[(4S,5R)-8-[2-(2-methoxyphenyl)ethynyl]-4-methyl-5-[[methyl-(phenylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C31H36N2O5S (548.2345)

(2S)-2-[(4S,5R)-8-[2-(2-methoxyphenyl)ethynyl]-4-methyl-5-[[methyl-(phenylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C31H36N2O5S (548.2345)

1-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-[4-(trifluoromethyl)phenyl]urea

C27H31F3N4O5 (548.2246)

1-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-[4-(trifluoromethyl)phenyl]urea

C27H31F3N4O5 (548.2246)

1-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-[4-(trifluoromethyl)phenyl]urea

C27H31F3N4O5 (548.2246)

1-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-[4-(trifluoromethyl)phenyl]urea

C27H31F3N4O5 (548.2246)

2-[(2S,4aR,12aR)-5-methyl-6-oxo-8-[(1-oxo-2-thiophen-2-ylethyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide

C29H32N4O5S (548.2093)

2-[(2R,4aS,12aS)-5-methyl-6-oxo-8-[(1-oxo-2-thiophen-2-ylethyl)amino]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide

C29H32N4O5S (548.2093)

(1S)-N1-(3,5-dimethyl-4-isoxazolyl)-N2-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxyspiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]-1,2-dicarboxamide

C28H29FN6O5 (548.2183)

bruceanol D

C28H36O11 (548.2258)

A quassinoid natural product found in Brucea antidysenterica consisting of a heteropentacyclic skeleton containing a delta-lactone moiety which is substituted at the alpha-carbon by a (2E)-3,4-dimethylpent-2-enoyloxy group. It shows significant in vitro cytotoxicity towards several human tumour cell lines.

SQMG 16:4

C25H40O11S (548.2291)

PA 14:1/8:3;O3

C25H41O11P (548.2386)

PA 22:4;O3

C25H41O11P (548.2386)

LPGP 15:1

C21H42O12P2 (548.2151)

LPGP O-16:1

C22H46O11P2 (548.2515)

LPGP P-16:0

C22H46O11P2 (548.2515)

ST 18:1;O8;GlcA

C24H36O14 (548.2105)

ST 19:0;O7;GlcA

C25H40O13 (548.2469)

ST 22:5;O5;GlcA

C28H36O11 (548.2258)

ST 19:1;O8;Hex

C25H40O13 (548.2469)

ST 22:6;O6;Hex

C28H36O11 (548.2258)

ST 25:2;O8;S

C25H40O11S (548.2291)

ST 28:7;O6;S

C28H36O9S (548.208)

ST 29:6;O5;S

C29H40O8S (548.2444)

[2,12,14-tris(acetyloxy)-3-hydroxy-4,13-dimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-8,10-dien-9-yl]methyl acetate

C28H36O11 (548.2258)

7-ethenyl-12-ethyl-21-hydroxy-6,11,27,28-tetramethyl-20-oxa-2,16,29,30-tetraazaheptacyclo[15.8.1.1³,²⁵.1⁵,⁸.1¹⁰,¹³.1¹⁵,¹⁸.0²¹,²⁶]triaconta-1,3,5,7,9,11,13(29),14,17(26),18(28)-decaene-19,22-dione

C33H32N4O4 (548.2423)

(8r,21s)-27-methoxy-22-methyl-15,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.2¹⁶,¹⁹.1⁴,³⁰.1¹⁰,¹⁴.0³,⁸.0²⁵,³³.0²⁸,³²]heptatriaconta-1,3,10,12,14(37),16,18,25(33),26,28(32),30(34),35-dodecaen-13-ol

C34H32N2O5 (548.2311)

4-hydroxy-2,5-bis[1-(2-methylbut-3-en-2-yl)indol-3-yl]-3,6-dioxocyclohexa-1,4-dien-1-yl acetate

C34H32N2O5 (548.2311)

(1r,2r,4s,6r,7s,9s,10s,11s,13r)-2,6,7-tris(acetyloxy)-13-hydroxy-5,5,9-trimethyl-14-methylidene-3,15-dioxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate

C28H36O11 (548.2258)

7,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-2,8-dihydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl benzoate

C28H36O11 (548.2258)

artanomaloide

C32H36O8 (548.241)

{"Ingredient_id": "HBIN016925","Ingredient_name": "artanomaloide","Alias": "NA","Ingredient_formula": "C32H36O8","Ingredient_Smile": "CC1=C2C(C3C(C(C1)OC(=O)C)C4(CC56C=CC4(C5C7C(CCC6(C)O)C(=C)C(=O)O7)C)C(=O)O3)C(=CC2=O)C","Ingredient_weight": "548.62","OB_score": "NA","CAS_id": "112823-41-3","SymMap_id": "NA","TCMID_id": "1781","TCMSP_id": "NA","TCM_ID_id": "6624","PubChem_id": "102005656","DrugBank_id": "NA"}

16,27-dimethoxy-29,31-dioxa-7,22-diazaoctacyclo[19.9.3.1⁴,³⁰.1¹⁰,¹⁴.1¹⁵,¹⁹.0³,⁸.0²⁵,³³.0²⁸,³²]hexatriaconta-1(30),2,4(34),10,12,14(36),15(35),16,18,25(33),26,28(32)-dodecaen-13-ol

C34H32N2O5 (548.2311)

(1r)-2-[(6ar,7r,8s,9r,10as)-9-{[(2r,3s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-oxooxan-2-yl]oxy}-7,8-dimethyl-3-oxo-1h,5h,6h,6ah,8h,9h,10h-naphtho[4,4a-c]furan-7-yl]-1-(furan-3-yl)ethyl acetate

C28H36O11 (548.2258)

(8s,21s)-16,27-dimethoxy-29,31-dioxa-7,22-diazaoctacyclo[19.9.3.1⁴,³⁰.1¹⁰,¹⁴.1¹⁵,¹⁹.0³,⁸.0²⁵,³³.0²⁸,³²]hexatriaconta-1(30),2,4(34),10,12,14(36),15(35),16,18,25(33),26,28(32)-dodecaen-13-ol

C34H32N2O5 (548.2311)

(8s,21r)-27-methoxy-22-methyl-15,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.2¹⁶,¹⁹.1⁴,³⁰.1¹⁰,¹⁴.0³,⁸.0²⁵,³³.0²⁸,³²]heptatriaconta-1,3,10,12,14(37),16,18,25(33),26,28(32),30(34),35-dodecaen-13-ol

C34H32N2O5 (548.2311)

(2s,3s,4s,5r)-6-{[(3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-{[(2r)-4-[(1r)-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl]butan-2-yl]oxy}oxan-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C25H40O13 (548.2469)

(4r)-5,5-dimethyl-4-[(1e,3r)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-1-en-1-yl]-3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)cyclohex-2-en-1-one

C25H40O13 (548.2469)

[(1s,2s,3s,4r,7s,8e,10e,12s,13r,14s)-2,12,14-tris(acetyloxy)-3-hydroxy-4,13,17-trimethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-8,10,16-trien-9-yl]methyl acetate

C28H36O11 (548.2258)

2,12-dimethyl 19,24-dihydroxy-2,8,12,18-tetramethyl-20,23-dioxoheptacyclo[12.6.2.2⁸,¹¹.0⁴,⁹.0⁵,⁷.0¹⁵,¹⁷.0¹⁸,²²]tetracosa-1(21),4(9),10,14(22)-tetraene-2,12-dicarboxylate

C32H36O8 (548.241)

(1s,2s,5s,6s,7s,8r,9r,12r)-8,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-2,5-dihydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C28H36O11 (548.2258)

(2r,2's,2''s,4'as,5'r,5''s,6'r,8's,8'ar)-2',2'',8'-tris(acetyloxy)-5''-(furan-3-yl)-6'-methyl-hexahydro-2'h-dispiro[oxirane-2,1'-naphthalene-5',3''-oxolan]-8'a-ylmethyl acetate

C28H36O11 (548.2258)

(2's,3ar,5'r,9's,9as,9br,10's)-2'-hydroxy-2',6,9,11'-tetramethyl-6'-methylidene-2,7,7'-trioxo-4,5,9a,9b-tetrahydro-3ah-8'-oxaspiro[azuleno[4,5-b]furan-3,12'-tetracyclo[9.2.2.0¹,¹⁰.0⁵,⁹]pentadecan]-14'-en-4-yl acetate

C32H36O8 (548.241)

(1ar,3r,3ar,4r,5r,6r,7as)-4,5-bis(acetyloxy)-6-[(3r,4r)-3-(2-methoxy-2-oxoethyl)-2,2,4-trimethyl-7-oxo-3h-oxepin-4-yl]-3a-methyl-7-methylidene-hexahydroindeno[1,7a-b]oxirene-3-carboxylic acid

C28H36O11 (548.2258)

2-{[1,5-bis(3,4-dimethoxyphenyl)-1-methoxypent-4-yn-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C28H36O11 (548.2258)

methyl (2r,3r,6r,8s,12s,13s,14s,15r,16r,17r)-3-{[(2e)-3,4-dimethylpent-2-enoyl]oxy}-12,15,16-trihydroxy-9,13-dimethyl-4,11-dioxo-5,19-dioxapentacyclo[12.5.0.0¹,⁶.0²,¹⁷.0⁸,¹³]nonadec-9-ene-17-carboxylate

C28H36O11 (548.2258)

(1'r,2'r,3r,3ar,4s,5's,9's,9as,9bs,10's,11'r)-2'-hydroxy-2',6,9,11'-tetramethyl-6'-methylidene-2,7,7'-trioxo-4,5,9a,9b-tetrahydro-3ah-8'-oxaspiro[azuleno[4,5-b]furan-3,12'-tetracyclo[9.2.2.0¹,¹⁰.0⁵,⁹]pentadecan]-14'-en-4-yl acetate

C32H36O8 (548.241)

(2s,3r,4s,5s,7s,9s,10e,13s)-2,4,5-tris(acetyloxy)-13-hydroxy-5,9,12,12-tetramethyl-8,14-dioxotricyclo[11.2.1.0³,⁷]hexadeca-1(15),10-dien-7-yl acetate

C28H36O11 (548.2258)

[(1s,2s,3s,4r,7s,8e,10z,12s,13r,14s)-2,12,14-tris(acetyloxy)-3-hydroxy-4,13-dimethyl-17-methylidene-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-8,10-dien-9-yl]methyl acetate

C28H36O11 (548.2258)

(1s,2s,5s,6s,7s,8r,9r,12r)-5,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-2,8-dihydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C28H36O11 (548.2258)

5,5-dimethyl-4-(3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-1-en-1-yl)-3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)cyclohex-2-en-1-one

C25H40O13 (548.2469)

1-[2-hydroxy-3,5-dimethyl-4,6-bis({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})phenyl]-2-methylpropan-1-one

C24H36O14 (548.2105)

2-{[3-hydroxy-2-(4-hydroxyphenyl)-4,5-dimethoxy-8-(3-methylbut-2-en-1-yl)-3,4-dihydro-2h-1-benzopyran-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C28H36O11 (548.2258)

methyl 3-[(3,4-dimethylpent-2-enoyl)oxy]-10,15,16-trihydroxy-9,13-dimethyl-4,11-dioxo-5,18-dioxapentacyclo[12.5.0.0¹,⁶.0²,¹⁷.0⁸,¹³]nonadec-9-ene-17-carboxylate

C28H36O11 (548.2258)

(1's,2'r,3r,3ar,4s,5'r,9's,9ar,9br,11's)-2'-hydroxy-2',6,9,11'-tetramethyl-6'-methylidene-2,7,7'-trioxo-4,5,9a,9b-tetrahydro-3ah-8'-oxaspiro[azuleno[4,5-b]furan-3,12'-tetracyclo[9.2.2.0¹,¹⁰.0⁵,⁹]pentadecan]-14'-en-4-yl acetate

C32H36O8 (548.241)

methyl 2-[(1ar,1bs,2r,6as)-6-[(2r)-2-[(1ar,1bs,2r,6as)-2-hydroxy-1b,6-dimethyl-3-oxo-1h,1ah,2h,6ah-cyclopropa[a]inden-4-yl]-3-methoxy-2-methyl-3-oxopropyl]-2-hydroxy-1b-methyl-3-oxo-1h,1ah,2h,6ah-cyclopropa[a]inden-4-yl]prop-2-enoate

C32H36O8 (548.241)

(2r,3r,4s,5s,6r)-2-{[(1s,2r)-1,5-bis(3,4-dimethoxyphenyl)-1-methoxypent-4-yn-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C28H36O11 (548.2258)

2-(9-{[3,5-dihydroxy-6-(hydroxymethyl)-4-oxooxan-2-yl]oxy}-7,8-dimethyl-3-oxo-1h,5h,6h,6ah,8h,9h,10h-naphtho[4,4a-c]furan-7-yl)-1-(furan-3-yl)ethyl acetate

C28H36O11 (548.2258)

2-{[3-(acetyloxy)-2-methyl-2-[(2-methylbut-2-enoyl)oxy]butanoyl]oxy}-1-(7-methoxy-2h-1,3-benzodioxol-5-yl)propyl 2-methylbut-2-enoate

C28H36O11 (548.2258)

(9r,10s)-10-hydroxy-4,5,14,15,16-pentamethoxy-9,10-dimethyltricyclo[10.4.0.0²,⁷]hexadeca-1(12),2(7),3,5,13,15-hexaen-3-yl (2e)-3-phenylprop-2-enoate

C32H36O8 (548.241)

2,4,5-tris(acetyloxy)-13-hydroxy-5,9,12,12-tetramethyl-8,14-dioxotricyclo[11.2.1.0³,⁷]hexadeca-1(15),10-dien-7-yl acetate

C28H36O11 (548.2258)

(1r,2r,7r,8z,11s,12s,13s,14r,16r,18s)-2,11,12-tris(acetyloxy)-4,9,13,18-tetramethyl-5-oxo-6,17-dioxatetracyclo[11.5.0.0³,⁷.0¹⁶,¹⁸]octadeca-3,8-dien-14-yl acetate

C28H36O11 (548.2258)

(1's,2's,3s,3ar,4s,6's,9'r,9as,9br,10's,13'r)-9'-hydroxy-6,9,9',13'-tetramethyl-5'-methylidene-2,4',7-trioxo-4,5,9a,9b-tetrahydro-3ah-3'-oxaspiro[azuleno[4,5-b]furan-3,12'-tetracyclo[8.3.2.0¹,¹⁰.0²,⁶]pentadecan]-14'-en-4-yl acetate

C32H36O8 (548.241)

2,12-dimethyl (2s,5r,7s,8r,12s,15r,17s,18r,19s,24s)-19,24-dihydroxy-2,8,12,18-tetramethyl-20,23-dioxoheptacyclo[12.6.2.2⁸,¹¹.0⁴,⁹.0⁵,⁷.0¹⁵,¹⁷.0¹⁸,²²]tetracosa-1(21),4(9),10,14(22)-tetraene-2,12-dicarboxylate

C32H36O8 (548.241)

n-[7,10-dimethyl-12-(2-methylpropyl)-2,5,9,11-tetraoxo-3-(sec-butyl)-1,4,8-trioxacyclododecan-6-yl]-2-hydroxy-3-[(hydroxymethylidene)amino]benzenecarboximidic acid

C27H36N2O10 (548.237)

4-hydroxy-2,5-bis[2-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]-3,6-dioxocyclohexa-1,4-dien-1-yl acetate

C34H32N2O5 (548.2311)

methyl 2-[2-hydroxy-6-(2-{2-hydroxy-1b,6-dimethyl-3-oxo-1h,1ah,2h,6ah-cyclopropa[a]inden-4-yl}-3-methoxy-2-methyl-3-oxopropyl)-1b-methyl-3-oxo-1h,1ah,2h,6ah-cyclopropa[a]inden-4-yl]prop-2-enoate

C32H36O8 (548.241)

(8s,21s)-7,22-dimethyl-15,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.2¹⁶,¹⁹.1⁴,³⁰.1¹⁰,¹⁴.0³,⁸.0²⁵,³³.0²⁸,³²]heptatriaconta-1(30),2,4(34),10,12,14(37),16,18,25(33),26,28(32),35-dodecaene-13,27-diol

C34H32N2O5 (548.2311)

(1r,2s,3r,4s,5s,6r,7r,8r,9r,12r,13s)-5,9-bis(acetyloxy)-3-(chloromethyl)-3,12,13-trihydroxy-6-isopropyl-9,13-dimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-4-yl acetate

C26H41ClO10 (548.2388)

14-(1-hydroxyethyl)-4,11,17-triisopropyl-19-oxa-6-thia-3,10,13,16,21,22-hexaazatricyclo[16.2.1.1⁵,⁸]docosa-1(20),2,5(22),7,9,12,15,18(21)-octaene-2,9,12,15-tetrol

C25H36N6O6S (548.2417)

2,12-dimethyl (2s,5r,7s,8r,12s,15r,17s,18s,19s,24s)-19,24-dihydroxy-2,8,12,18-tetramethyl-20,23-dioxoheptacyclo[12.6.2.2⁸,¹¹.0⁴,⁹.0⁵,⁷.0¹⁵,¹⁷.0¹⁸,²²]tetracosa-1(21),4(9),10,14(22)-tetraene-2,12-dicarboxylate

C32H36O8 (548.241)

(4s,11s,14s,17s)-14-[(1r)-1-hydroxyethyl]-4,11,17-triisopropyl-19-oxa-6-thia-3,10,13,16,21,22-hexaazatricyclo[16.2.1.1⁵,⁸]docosa-1(20),2,5(22),7,9,12,15,18(21)-octaene-2,9,12,15-tetrol

C25H36N6O6S (548.2417)

5,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-2,8-dihydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C28H36O11 (548.2258)

(1's,2'r,3r,3ar,4s,5's,9's,9as,9br,10's,11's)-2'-hydroxy-2',6,9,11'-tetramethyl-6'-methylidene-2,7,7'-trioxo-4,5,9a,9b-tetrahydro-3ah-8'-oxaspiro[azuleno[4,5-b]furan-3,12'-tetracyclo[9.2.2.0¹,¹⁰.0⁵,⁹]pentadecan]-14'-en-4-yl acetate

C32H36O8 (548.241)

(8r,21r)-27-methoxy-22-methyl-15,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.2¹⁶,¹⁹.1⁴,³⁰.1¹⁰,¹⁴.0³,⁸.0²⁵,³³.0²⁸,³²]heptatriaconta-1,3,10,12,14(37),16,18,25(33),26,28(32),30(34),35-dodecaen-13-ol

C34H32N2O5 (548.2311)

[(1r,3as,3br,5as,7s,8s,9as,9bs,11ar)-1-[(2r)-hept-6-en-2-yl]-9a,11a-dimethyl-8-(sulfooxy)-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxidanesulfonic acid

C26H44O8S2 (548.2477)

9'-hydroxy-6,9,9',13'-tetramethyl-5'-methylidene-2,4',7-trioxo-4,5,9a,9b-tetrahydro-3ah-3'-oxaspiro[azuleno[4,5-b]furan-3,12'-tetracyclo[8.3.2.0¹,¹⁰.0²,⁶]pentadecan]-14'-en-4-yl acetate

C32H36O8 (548.241)

(1r,2r,4s,7r,8s,10s,11s,12r,13s,18s)-7-[(5r)-5-ethoxy-2-oxo-5h-furan-3-yl]-10,13-dihydroxy-1,8,12,17,17-pentamethyl-3,6,16-trioxapentacyclo[9.9.0.0²,⁴.0²,⁸.0¹²,¹⁸]icosane-5,15,20-trione

C28H36O11 (548.2258)

(1s,2s,3s,7s,8r,9r,10s,12z,14s,17r)-7,9,10-tris(acetyloxy)-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadeca-4,12-dien-2-yl acetate

C28H36O11 (548.2258)

(2s,3r,4s,5s,6r)-2-{[(2r,3s,4s)-3-hydroxy-2-(4-hydroxyphenyl)-4,5-dimethoxy-8-(3-methylbut-2-en-1-yl)-3,4-dihydro-2h-1-benzopyran-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C28H36O11 (548.2258)

2',2'',8'-tris(acetyloxy)-5''-(furan-3-yl)-6'-methyl-hexahydro-2'h-dispiro[oxirane-2,1'-naphthalene-5',3''-oxolan]-8'a-ylmethyl acetate

C28H36O11 (548.2258)

(2s,3r,4s,5s,7s,9s,10e,13r)-2,4,5-tris(acetyloxy)-13-hydroxy-5,9,12,12-tetramethyl-8,14-dioxotricyclo[11.2.1.0³,⁷]hexadeca-1(15),10-dien-7-yl acetate

C28H36O11 (548.2258)

methyl (1r,2s,3r,6r,8s,9s,13s,14s,15r,16s,17r)-3-{[(2e)-3,4-dimethylpent-2-enoyl]oxy}-11,15,16-trihydroxy-9,13-dimethyl-4,12-dioxo-5,18-dioxapentacyclo[12.5.0.0¹,⁶.0²,¹⁷.0⁸,¹³]nonadec-10-ene-17-carboxylate

C28H36O11 (548.2258)

(8s,21s)-13,27-dimethoxy-15,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.2¹⁶,¹⁹.1⁴,³⁰.1¹⁰,¹⁴.0³,⁸.0²⁵,³³.0²⁸,³²]heptatriaconta-1,3,10,12,14(37),16,18,25,27,30(34),32,35-dodecaene

C34H32N2O5 (548.2311)

7,22-dimethyl-15,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.2¹⁶,¹⁹.1⁴,³⁰.1¹⁰,¹⁴.0³,⁸.0²⁵,³³.0²⁸,³²]heptatriaconta-1(30),2,4(34),10,12,14(37),16,18,25(33),26,28(32),35-dodecaene-13,27-diol

C34H32N2O5 (548.2311)

7-(5-ethoxy-2-oxo-5h-furan-3-yl)-10,13-dihydroxy-1,8,12,17,17-pentamethyl-3,6,16-trioxapentacyclo[9.9.0.0²,⁴.0²,⁸.0¹²,¹⁸]icosane-5,15,20-trione

C28H36O11 (548.2258)

(2r,3s)-3-(acetyloxy)-1-{[(1s,2r)-1-(7-methoxy-2h-1,3-benzodioxol-5-yl)-1-{[(2z)-2-methylbut-2-enoyl]oxy}propan-2-yl]oxy}-2-methyl-1-oxobutan-2-yl (2z)-2-methylbut-2-enoate

C28H36O11 (548.2258)

(2's,3ar,4s,5's,9's,9as,9br,10's,11'r)-4-hydroxy-2',6,9,11'-tetramethyl-6'-methylidene-2,7,7'-trioxo-4,5,9a,9b-tetrahydro-3ah-8'-oxaspiro[azuleno[4,5-b]furan-3,12'-tetracyclo[9.2.2.0¹,¹⁰.0⁵,⁹]pentadecan]-14'-en-2'-yl acetate

C32H36O8 (548.241)

10-hydroxy-4,5,14,15,16-pentamethoxy-9,10-dimethyltricyclo[10.4.0.0²,⁷]hexadeca-1(12),2(7),3,5,13,15-hexaen-3-yl 3-phenylprop-2-enoate

C32H36O8 (548.241)

6-{[(1s,2s,3r,4ar,4bs,7s,10ar)-7-(2-chloro-1-hydroxyethyl)-2,3-dihydroxy-1,4a,7-trimethyl-3,4,4b,5,6,8,10,10a-octahydro-2h-phenanthren-1-yl]methoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C26H41ClO10 (548.2388)

(2's,3s,3ar,5'r,9's,9as,9br,10's)-2'-hydroxy-2',6,9,11'-tetramethyl-6'-methylidene-2,7,7'-trioxo-4,5,9a,9b-tetrahydro-3ah-8'-oxaspiro[azuleno[4,5-b]furan-3,12'-tetracyclo[9.2.2.0¹,¹⁰.0⁵,⁹]pentadecan]-14'-en-4-yl acetate

C32H36O8 (548.241)

(8s,21s)-27-methoxy-7-methyl-15,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.2¹⁶,¹⁹.1⁴,³⁰.1¹⁰,¹⁴.0³,⁸.0²⁵,³³.0²⁸,³²]heptatriaconta-1,3,10,12,14(37),16,18,25(33),26,28(32),30(34),35-dodecaen-13-ol

C34H32N2O5 (548.2311)

6-{[7-(2-chloro-1-hydroxyethyl)-2,3-dihydroxy-1,4a,7-trimethyl-3,4,4b,5,6,8,10,10a-octahydro-2h-phenanthren-1-yl]methoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C26H41ClO10 (548.2388)

(8r,21s)-16,27-dimethoxy-29,31-dioxa-7,22-diazaoctacyclo[19.9.3.1⁴,³⁰.1¹⁰,¹⁴.1¹⁵,¹⁹.0³,⁸.0²⁵,³³.0²⁸,³²]hexatriaconta-1(30),2,4(34),10,12,14(36),15(35),16,18,25(33),26,28(32)-dodecaen-13-ol

C34H32N2O5 (548.2311)

(1s,2s,5s,6s,7s,8s,9r,12r)-7,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-2,8-dihydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl benzoate

C28H36O11 (548.2258)

2,11,12-tris(acetyloxy)-4,9,13,18-tetramethyl-5-oxo-6,17-dioxatetracyclo[11.5.0.0³,⁷.0¹⁶,¹⁸]octadeca-3,8-dien-14-yl acetate

C28H36O11 (548.2258)

27-methoxy-22-methyl-15,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.2¹⁶,¹⁹.1⁴,³⁰.1¹⁰,¹⁴.0³,⁸.0²⁵,³³.0²⁸,³²]heptatriaconta-1,3,10,12,14(37),16,18,25(33),26,28(32),30(34),35-dodecaen-13-ol

C34H32N2O5 (548.2311)

(8s,21s)-27-methoxy-22-methyl-15,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.2¹⁶,¹⁹.1⁴,³⁰.1¹⁰,¹⁴.0³,⁸.0²⁵,³³.0²⁸,³²]heptatriaconta-1,3,10,12,14(37),16,18,25(33),26,28(32),30(34),35-dodecaen-13-ol

C34H32N2O5 (548.2311)

4-[2-(benzyloxy)-4-methoxy-6-(2-oxononyl)benzoyloxy]-2-hydroxy-6-methylbenzoic acid

C32H36O8 (548.241)